Table 2 Baseline characteristics of the trial patients
Characteristic | Group S(n = 30) | Group N(n = 28) | Statistical value | P value |
|---|---|---|---|---|
Gender (male/female) | 19/11 | 18/10 | χ2 = 0.006 | 0.940 |
Age (years old) | 60.23 ± 10.56 | 63.43 ± 10.00 | t=-1.181 | 0.242 |
BMI | 24.36 ± 2.60 | 23.37 ± 3.08 | t = 1.320 | 0.192 |
ASA score |  |  | χ2 = 0.291 | 0.864 |
1 | 2(6.7%) | 1(3.6%) | Â | Â |
2 | 25(83.3%) | 24(85.7%) | Â | Â |
3 | 3(10.0%) | 3(10.7%) | Â | Â |
4 | 0 | 0 | Â | Â |
Previous hepatectomy | 1(3.3%) | 1(3.6%) | χ2<0.001 | >0.999 |
Postoperative interventional therapy was needed | 8(26.7%) | 9(32.1%) | χ2 = 0.210 | 0.647 |
Postoperative Chemotherapy is Required | 7(23.3%) | 4(14.3%) | χ2 = 0.771 | 0.380 |